Mangiferin has demonstrated in vitro inhibitory influence on RANKL (Receptor Activator of
Nuclear Factor Kappa B Ligand) mediated osteoclasts activity. In this study we evaluated the …

Osteolytic bone diseases such as osteoporosis have a common pathological feature in
which osteoclastic bone resorption outstrips bone synthesis. Osteoclast formation and …

Mangiferin is a xanthone glucoside extracted from multiple plants, which has been shown to
inhibit bone resorption and alleviate osteoporosis. However, the effect of purified Mangiferin …

Mangiferin is a polyphenolic compound present in Salacia reticulata. It has been reported to
reduce bone destruction and inhibit osteoclastic differentiation. This study aimed to …

Poncirin, a flavonoid isolated from the fruit of Poncirus trifoliata, possesses anti-bacterial and
anti-inflammatory activities. However, the action of poncirin in bone biology is unclear. In this …

Metabolism of bone is regulated by the balance between osteoblast‐mediated bone
formation and osteoclast‐mediated bone resorption. Activation of osteoclasts could lead to …

Objective Hormone replacement therapy has been used as an effective treatment for the
prevention of bone loss in postmenopausal women. In our previous study, QiBaoMeiRan …

Osteoporosis is a widespread problem afflicting millions of people. Drynol Cibotinis is a
newly developed proprietary botanical combination of eight botanicals including Angelica …

abstract Ethnopharmacological relevance: Recent research has confirmed that Cibotium
barometz could inhibits osteoclast formation with no affect on BMM cell viability. However …

A flavonoid fraction of Herba Epimedii, including eight flavonoid glycoside compounds,
epimedoside A, ikarisoside F, baohuoside II, sagittatoside A, sagittatoside B, 7-O-rhamnosyl …